CLRB Annual Operating Expenses
$38.96 M
+$10.15 M+35.22%
31 December 2023
Summary:
As of January 23, 2025, CLRB annual total operating expenses is $38.96 million, with the most recent change of +$10.15 million (+35.22%) on December 31, 2023. During the last 3 years, it has risen by +$23.67 million (+154.81%). CLRB annual operating expenses is now at all-time high.CLRB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Quarterly Operating Expenses
$13.33 M
-$376.00 K-2.74%
30 September 2024
Summary:
As of January 23, 2025, CLRB quarterly total operating expenses is $13.33 million, with the most recent change of -$376.00 thousand (-2.74%) on September 30, 2024. Over the past year, it has increased by +$779.80 thousand (+6.21%). CLRB quarterly operating expenses is now -2.74% below its all-time high of $13.70 million, reached on June 30, 2024.CLRB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.2% | +6.2% |
| 3 y3 years | +154.8% | +129.0% |
| 5 y5 years | +234.3% | +236.2% |
CLRB Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.5% | -2.7% | +125.0% |
| 5 y | 5-year | at high | +174.8% | -2.7% | +293.8% |
| alltime | all time | at high | +1410.7% | -2.7% | +3674.5% |
Cellectar Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.33 M(-2.7%) |
| June 2024 | - | $13.70 M(+14.2%) |
| Mar 2024 | - | $12.00 M(-4.4%) |
| Dec 2023 | $38.96 M(+35.2%) | $12.55 M(+33.3%) |
| Sept 2023 | - | $9.41 M(+13.5%) |
| June 2023 | - | $8.29 M(-4.7%) |
| Mar 2023 | - | $8.71 M(+17.3%) |
| Dec 2022 | $28.81 M(+19.4%) | $7.42 M(-5.0%) |
| Sept 2022 | - | $7.82 M(+5.1%) |
| June 2022 | - | $7.44 M(+21.1%) |
| Mar 2022 | - | $6.14 M(+3.7%) |
| Dec 2021 | $24.13 M(+57.8%) | $5.92 M(+1.8%) |
| Sept 2021 | - | $5.82 M(-3.5%) |
| June 2021 | - | $6.03 M(-5.2%) |
| Mar 2021 | - | $6.36 M(+67.4%) |
| Dec 2020 | $15.29 M(+7.8%) | $3.80 M(-2.8%) |
| Sept 2020 | - | $3.91 M(+7.9%) |
| June 2020 | - | $3.62 M(-8.5%) |
| Mar 2020 | - | $3.96 M(+17.0%) |
| Dec 2019 | $14.18 M(+21.6%) | $3.38 M(-14.6%) |
| Sept 2019 | - | $3.96 M(+23.9%) |
| June 2019 | - | $3.20 M(-11.8%) |
| Mar 2019 | - | $3.63 M(+64.3%) |
| Dec 2018 | $11.66 M(-14.3%) | $2.21 M(-28.4%) |
| Sept 2018 | - | $3.09 M(+6.3%) |
| June 2018 | - | $2.90 M(-15.9%) |
| Mar 2018 | - | $3.45 M(-15.5%) |
| Dec 2017 | $13.60 M(+43.9%) | $4.09 M(+17.4%) |
| Sept 2017 | - | $3.48 M(+8.3%) |
| June 2017 | - | $3.22 M(+14.4%) |
| Mar 2017 | - | $2.81 M(+6.2%) |
| Dec 2016 | $9.45 M(+10.5%) | $2.65 M(+7.3%) |
| Sept 2016 | - | $2.47 M(+5.8%) |
| June 2016 | - | $2.33 M(+16.6%) |
| Mar 2016 | - | $2.00 M(+13.5%) |
| Dec 2015 | $8.55 M(-11.5%) | $1.76 M(-11.9%) |
| Sept 2015 | - | $2.00 M(-9.0%) |
| June 2015 | - | $2.20 M(-14.9%) |
| Mar 2015 | - | $2.59 M(+14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $9.67 M(-14.5%) | $2.25 M(-0.9%) |
| Sept 2014 | - | $2.27 M(-2.9%) |
| June 2014 | - | $2.34 M(-16.5%) |
| Mar 2014 | - | $2.80 M(-5.3%) |
| Dec 2013 | $11.30 M(+29.1%) | $2.96 M(+1.7%) |
| Sept 2013 | - | $2.91 M(+6.9%) |
| June 2013 | - | $2.72 M(+0.4%) |
| Mar 2013 | - | $2.71 M(+25.4%) |
| Dec 2012 | $8.75 M(+39.2%) | $2.16 M(+5.3%) |
| Sept 2012 | - | $2.05 M(-7.1%) |
| June 2012 | - | $2.21 M(-4.9%) |
| Mar 2012 | - | $2.33 M(+15.2%) |
| Dec 2011 | $6.29 M(+51.9%) | $2.02 M(+5.6%) |
| Sept 2011 | - | $1.91 M(+8.7%) |
| June 2011 | - | $1.76 M(+191.6%) |
| Mar 2011 | - | $603.10 K(+18.3%) |
| Dec 2010 | $4.14 M(-59.7%) | $509.80 K(-16.0%) |
| Sept 2010 | - | $607.10 K(-60.3%) |
| June 2010 | - | $1.53 M(-40.1%) |
| Mar 2010 | - | $2.56 M(-28.9%) |
| Dec 2009 | $10.26 M(-38.6%) | $3.60 M(+55.6%) |
| Sept 2009 | - | $2.31 M(+10.3%) |
| June 2009 | - | $2.10 M(-7.3%) |
| Mar 2009 | - | $2.26 M(+3.4%) |
| Dec 2008 | $16.72 M(-17.6%) | $2.19 M(-15.7%) |
| Sept 2008 | - | $2.59 M(-45.5%) |
| June 2008 | - | $4.76 M(-33.6%) |
| Mar 2008 | - | $7.17 M(+7.2%) |
| Dec 2007 | $20.29 M(+127.3%) | $6.70 M(+0.8%) |
| Sept 2007 | - | $6.65 M(+49.8%) |
| June 2007 | - | $4.44 M(+76.3%) |
| Mar 2007 | - | $2.52 M(-11.4%) |
| Dec 2006 | $8.93 M(+246.3%) | $2.84 M(-5.2%) |
| Sept 2006 | - | $3.00 M(+80.5%) |
| June 2006 | - | $1.66 M(+15.7%) |
| Mar 2006 | - | $1.43 M(+92.2%) |
| Dec 2005 | $2.58 M | $746.60 K(-23.3%) |
| Sept 2005 | - | $973.30 K(+92.4%) |
| June 2005 | - | $506.00 K(+43.3%) |
| Mar 2005 | - | $353.10 K |
FAQ
- What is Cellectar Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Cellectar Biosciences?
- What is Cellectar Biosciences annual operating expenses year-on-year change?
- What is Cellectar Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly operating expenses year-on-year change?
What is Cellectar Biosciences annual total operating expenses?
The current annual operating expenses of CLRB is $38.96 M
What is the all time high annual operating expenses for Cellectar Biosciences?
Cellectar Biosciences all-time high annual total operating expenses is $38.96 M
What is Cellectar Biosciences annual operating expenses year-on-year change?
Over the past year, CLRB annual total operating expenses has changed by +$10.15 M (+35.22%)
What is Cellectar Biosciences quarterly total operating expenses?
The current quarterly operating expenses of CLRB is $13.33 M
What is the all time high quarterly operating expenses for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly total operating expenses is $13.70 M
What is Cellectar Biosciences quarterly operating expenses year-on-year change?
Over the past year, CLRB quarterly total operating expenses has changed by +$779.80 K (+6.21%)